Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Overt Hypothyroidism Following RAI for Graves' Disease
NCT01950260Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium in hypothyroidism, sponsored by Mayo Clinic. Started Sep 2013; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT01950260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950260.